Thierry Lafont
- Oncology
- Molecular Biology
- Hepatology top 10%
- Genetics top 10%
- Hematology top 10%
- Co-authors
- Étienne ChatelutLionel RostaingNassim KamarFlorent PuissetJacques IzopetCécile ArellanoEfthymios ManolisPeggy Gandia
- Topics
- Cancer Treatment and Pharmacology (6 papers)Chemotherapy-induced organ toxicity mitigation (6 papers)Colorectal Cancer Treatments and Studies (5 papers)
- Cited by
- HepatologyGeneticsTransplantation
- Partner nations
- FranceUnited KingdomNetherlands
In The Last Decade
Thierry Lafont
23 papers receiving 589 citations
Peers
Comparison fields: 5 of 88
- Oncology 197
- Molecular Biology 113
- Hepatology 107
- Genetics 94
- Hematology 91
Countries citing papers authored by Thierry Lafont
This map shows the geographic impact of Thierry Lafont's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thierry Lafont with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thierry Lafont more than expected).
Fields of papers citing papers by Thierry Lafont
This network shows the impact of papers produced by Thierry Lafont. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thierry Lafont. The network helps show where Thierry Lafont may publish in the future.
Co-authorship network of co-authors of Thierry Lafont
This figure shows the co-authorship network connecting the top 25 collaborators of Thierry Lafont. A scholar is included among the top collaborators of Thierry Lafont based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thierry Lafont. Thierry Lafont is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 4 | |
| 3 | 12 | |
| 4 | 19 | |
| 5 | 7 | |
| 6 | 12 | |
| 7 | 29 | |
| 8 | 12 | |
| 9 | 25 | |
| 10 | 17 | |
| 11 | 59 | |
| 12 | 25 | |
| 13 | 35 | |
| 14 | 29 | |
| 15 | 30 | |
| 16 | 11 | |
| 17 | 32 | |
| 18 | 53 | |
| 19 | 64 | |
| 20 | 33 |
About Thierry Lafont
Thierry Lafont is a scholar working on Pathology and Forensic Medicine, Oncology and Transplantation, having authored 24 papers that have together received 607 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (6 papers), Chemotherapy-induced organ toxicity mitigation (6 papers) and Colorectal Cancer Treatments and Studies (5 papers). The work is most often cited by research in Hepatology (107 citations), Genetics (94 citations) and Transplantation (22 citations). Thierry Lafont has collaborated with scholars based in France, United Kingdom and Netherlands. Frequent co-authors include Étienne Chatelut, Lionel Rostaing, Nassim Kamar, Florent Puisset, Jacques Izopet, Cécile Arellano, Efthymios Manolis, Peggy Gandia, Fabienne Thomas and Jean‐Pierre Delord. Their work appears in journals such as Journal of Clinical Oncology, Pharmaceutical Research and American Journal of Kidney Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.